Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory examination, and pathological activation, and a platform to help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of the disease involves the development of individual characteristics, typically including drug therapy, rehabilitation interventions, regular follow-up, and multi-dimensional management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune disorders that were previously difficult to treat have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for Greig's comprehensive management of multiple and indicated syndromes. The platform serves the China International Medical Service System, a team of domestically authoritative experts in the field of autoimmune and rheumatic immunity, to provide the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.